rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

J. Scott Nixon

Director

Company insider

Files Form 4 as: Director, USANA Health Sciences; Director, Prolung.

Every Form 4 they filed

In numbers

Trades disclosed
60
Buys
0
Sells
1
Bought
$0
Sold
$165K
Companies
2
Companies where not an officer
2
First trade
24 Aug 2017
Last trade
23 Jul 2026
Last filed
27 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
USNA USANA Health SciencesDirector · Pharmaceuticals · last 23 Jul 20260 buys · 1 sell
ProlungDirector · last 8 May 20180 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
23 Jul 2026filed 27 Jul 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—1,632filing
23 Jul 2026filed 27 Jul 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,632 at $0.00filing
23 Jul 2026filed 27 Jul 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,632 at $0.00filing
23 Jul 2026filed 27 Jul 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—1,632filing
7 May 2026filed 11 May 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—6,527 at $0.00filing
7 May 2026filed 11 May 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—6,527 at $0.00filing
23 Apr 2026filed 27 Apr 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—1,057filing
23 Apr 2026filed 27 Apr 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,057 at $0.00filing
23 Apr 2026filed 27 Apr 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,057 at $0.00filing
23 Apr 2026filed 27 Apr 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—1,057filing
22 Jan 2026filed 26 Jan 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—1,058filing
22 Jan 2026filed 26 Jan 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,058 at $0.00filing
22 Jan 2026filed 26 Jan 2026USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,058 at $0.00filing
22 Jan 2026filed 26 Jan 2026USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—1,058filing
23 Oct 2025filed 27 Oct 2025USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,057 at $0.00filing
23 Oct 2025filed 27 Oct 2025USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—1,057filing
24 Jul 2025filed 28 Jul 2025USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—1,058 at $0.00filing
24 Jul 2025filed 28 Jul 2025USNA USANA Health SciencesPharmaceuticalsSEC FORM 4 Code M—1,058filing
20 May 2025filed 21 May 2025USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—4,230 at $0.00filing
2 May 2025filed 6 May 2025USNA USANA Health Sciencesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—674 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Gilbert A. FullerDirector · Director at Usana Health Sciences, filing Form 4 there in the last year
Timothy E. WoodDirector · Director at Usana Health Sciences, filing Form 4 there in the last year
Frederic J. WinssingerDirector · Director at Usana Health Sciences, filing Form 4 there in the last year
Peggie PelosiDirector · Director at Usana Health Sciences, filing Form 4 there in the last year
John Turman FlemingDirector · Director at Usana Health Sciences, filing Form 4 there in the last year